Oncology Pharma Inc. (ONPH)

OTCMKTS · Delayed Price · Currency is USD

0.0550

+0.0049 (9.78%)

At close: Jul 30, 2026

Oncology Pharma Financials Overview

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2013	FY 2011	FY 2004	FY 2003	FY 2002
Period Ending	Mar '13 Mar 31, 2013	Mar '13 Mar 31, 2013	Jun '11 Jun 30, 2011	Mar '04 Mar 31, 2004	Mar '03 Mar 31, 2003	Mar '02 Mar 31, 2002
Revenue	0.01	0.01	0.13	1.18	3.28	3.67
Revenue Growth	-98.44%	-92.42%	-88.59%	-63.99%	-10.67%	-8.48%
Gross Profit	0.01	0.01	0.13	0.53	2.07	2.31
Operating Income	-0.01	-0.01	0.06	-1.7	-1.5	-2.02
Net Income	0.19	0.19	0.06	-1.57	-1.52	-1.95

Cash & Debt

Fiscal Year	Current	FY 2013	FY 2011	FY 2004	FY 2003	FY 2002
Period Ending	Mar '13 Mar 31, 2013	Mar '13 Mar 31, 2013	Jun '11 Jun 30, 2011	Mar '04 Mar 31, 2004	Mar '03 Mar 31, 2003	Mar '02 Mar 31, 2002
Cash & Investments	0.01	0.01	0	0.01	1.35	2.93
Total Debt	0.41	0.41	0.66	0.03	-	-
Net Cash (Debt)	-0.4	-0.4	-0.66	-0.02	1.35	2.93
Net Cash Growth	-	-	-	-	-54.12%	-28.02%

Cash Flow & CapEx

Fiscal Year	TTM	FY 2013	FY 2011	FY 2004	FY 2003	FY 2002
Period Ending	Mar '13 Mar 31, 2013	Mar '13 Mar 31, 2013	Jun '11 Jun 30, 2011	Mar '04 Mar 31, 2004	Mar '03 Mar 31, 2003	Mar '02 Mar 31, 2002
Operating Cash Flow	0.01	0.01	-	-2	-1.44	-1.45
Capital Expenditures	-0.01	-0.01	-	-0.02	-0.15	-0.32
Free Cash Flow	0	0	-	-2.02	-1.59	-1.77
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2013	FY 2011	FY 2004	FY 2003	FY 2002
Period Ending	Mar '13 Mar 31, 2013	Mar '13 Mar 31, 2013	Jun '11 Jun 30, 2011	Mar '04 Mar 31, 2004	Mar '03 Mar 31, 2003	Mar '02 Mar 31, 2002
Gross Margin	100.00%	100.00%	100.00%	44.62%	63.05%	63.02%
Operating Margin	-141.66%	-141.66%	44.19%	-144.03%	-45.85%	-54.90%
Pretax Margin	-141.66%	-141.66%	44.19%	-132.51%	-46.34%	-53.13%
Profit Margin	1821.37%	1821.37%	43.60%	-132.52%	-46.34%	-53.13%
FCF Margin	7.25%	7.25%	-	-170.79%	-48.51%	-48.28%